While I enjoyed stats in college (and was good at
Post# of 154553
The good news is, we should get this from the ESMO poster.....this also shows the importance to have proper trial protocol because if we only accept patients with an extremely unfavorable prognosis who have failed 3+ treatments a) the mOS data points can be largely skewed for patients grasping for anything at that point and b) the patient population is smaller so less patients to enroll to achieve larger population for more accurate / less skewed results.


